Also, going back through old trial agreement announcements it is pretty easy to deduce the revenue figures he was reluctant to disclose. Multiplied by even a fraction of the 5000 trials he flagged, we are talking about monstrous revenue.
Great to see $1.50 valuation now because it gives perspective. With a few more trial agreements under the belt I think even the most hardened critics would find it hard to disagree that we are looking at a multi billion dollar company in the future.
Add to My Watchlist
What is My Watchlist?
